NX
NXNVW
NEXTNAV INC.
No data for this timeframe.
Vol
SEC Reports4
Exchange OTC·Sector Search, Detection, Navigation, Guidance, Aeronautical Sys·Inc. DE·CIK 0001865631
Recent Activity
May 27, 2026
SEC
NextNav has announced a mandatory cash redemption of all ~10M outstanding public warrants (NNAVW), exercisable at $11.50
8-K — Impact 6/10
May 26, 2026
SEC
NextNav filed an automatic shelf registration (S-3ASR) to register 15,100,000 shares of common stock issuable upon exerc
S-3ASR — Impact 6/10
May 14, 2026
SEC
NextNav reported Q1 2026 revenue of $995K, down 35% YoY and narrowly above $944K consensus, while operating loss widened
8-K — Impact 6/10
Latest Reports
BULLISH
8-K
6/10
NextNav has announced a mandatory cash redemption of all ~10M outstanding public warrants (NNAVW), exercisable at $11.50
May 27, 2026
BEARISH
S-3ASR
6/10
NextNav filed an automatic shelf registration (S-3ASR) to register 15,100,000 shares of common stock issuable upon exerc
May 26, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 1 bullish, 2 bearish, 0 mixed, 1 neutral. Avg impact: 5.3/10.
BULLISH
8-K
6/10
NextNav has announced a mandatory cash redemption of all ~10M outstanding public warrants (NNAVW), e
May 27, 2026
BEARISH
S-3ASR
6/10
NextNav filed an automatic shelf registration (S-3ASR) to register 15,100,000 shares of common stock
May 26, 2026
BEARISH
8-K
6/10
NextNav reported Q1 2026 revenue of $995K, down 35% YoY and narrowly above $944K consensus, while op
May 14, 2026
NEUTRAL
DEFA14A
3/10
Analysis based on filing metadata only — document content was unavailable
Apr 8, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -25.1% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 7.1% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -17.0% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -15.7% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.